Active Ingredient(s): Diroximel Fumarate
FDA Approved: * October 29, 2019
Pharm Company: * BIOGEN
Category: Multiple Sclerosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Recent Vumerity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Diroximel Fumarate
  • Capsule, Delayed Release: 120mg, 231mg, 240mg
  • Solution: 50%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vumerity: (1 result)

Sorted by National Drug Code
  • 64406-020 Vumerity 231 mg Oral Capsule by Biogen Inc.

Other drugs which contain Diroximel Fumarate or a similar ingredient: (4 results)